1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Wet Age-Related Macular Degeneration (Wet AMD) 1.2.3 Dry Age-Related Macular Degeneration (Dry AMD) 1.3 Market by Application 1.3.1 Global Wet Age Related Macular Degeneration (AMD) Market Share by Age: 2016 VS 2021 VS 2027 1.3.2 Above 75 Years 1.3.3 Above 60 Years 1.3.4 Above 40 Years 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Wet Age Related Macular Degeneration (AMD) Market Perspective (2016-2027) 2.2 Wet Age Related Macular Degeneration (AMD) Growth Trends by Regions 2.2.1 Wet Age Related Macular Degeneration (AMD) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Wet Age Related Macular Degeneration (AMD) Historic Market Share by Regions (2016-2021) 2.2.3 Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Regions (2022-2027) 2.3 Wet Age Related Macular Degeneration (AMD) Industry Dynamic 2.3.1 Wet Age Related Macular Degeneration (AMD) Market Trends 2.3.2 Wet Age Related Macular Degeneration (AMD) Market Drivers 2.3.3 Wet Age Related Macular Degeneration (AMD) Market Challenges 2.3.4 Wet Age Related Macular Degeneration (AMD) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Wet Age Related Macular Degeneration (AMD) Players by Revenue 3.1.1 Global Top Wet Age Related Macular Degeneration (AMD) Players by Revenue (2016-2021) 3.1.2 Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2016-2021) 3.2 Global Wet Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Wet Age Related Macular Degeneration (AMD) Revenue 3.4 Global Wet Age Related Macular Degeneration (AMD) Market Concentration Ratio 3.4.1 Global Wet Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Wet Age Related Macular Degeneration (AMD) Revenue in 2020 3.5 Wet Age Related Macular Degeneration (AMD) Key Players Head office and Area Served 3.6 Key Players Wet Age Related Macular Degeneration (AMD) Product Solution and Service 3.7 Date of Enter into Wet Age Related Macular Degeneration (AMD) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Wet Age Related Macular Degeneration (AMD) Breakdown Data by Type 4.1 Global Wet Age Related Macular Degeneration (AMD) Historic Market Size by Type (2016-2021) 4.2 Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2022-2027) 5 Wet Age Related Macular Degeneration (AMD) Breakdown Data by Age 5.1 Global Wet Age Related Macular Degeneration (AMD) Historic Market Size by Age (2016-2021) 5.2 Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Age (2022-2027) 6 North America 6.1 North America Wet Age Related Macular Degeneration (AMD) Market Size (2016-2027) 6.2 North America Wet Age Related Macular Degeneration (AMD) Market Size by Type 6.2.1 North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) 6.2.2 North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2022-2027) 6.2.3 North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2027) 6.3 North America Wet Age Related Macular Degeneration (AMD) Market Size by Age 6.3.1 North America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2021) 6.3.2 North America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2022-2027) 6.3.3 North America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2027) 6.4 North America Wet Age Related Macular Degeneration (AMD) Market Size by Country 6.4.1 North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2016-2021) 6.4.2 North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size (2016-2027) 7.2 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type 7.2.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) 7.2.2 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2022-2027) 7.2.3 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2027) 7.3 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age 7.3.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2021) 7.3.2 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age (2022-2027) 7.3.3 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2027) 7.4 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country 7.4.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2016-2021) 7.4.2 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size (2016-2027) 8.2 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Type 8.2.1 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2027) 8.3 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Age 8.3.1 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2021) 8.3.2 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Age (2022-2027) 8.3.3 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2027) 8.4 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region 8.4.1 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Wet Age Related Macular Degeneration (AMD) Market Size (2016-2027) 9.2 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type 9.2.1 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) 9.2.2 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2022-2027) 9.2.3 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2027) 9.3 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age 9.3.1 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2021) 9.3.2 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2022-2027) 9.3.3 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2027) 9.4 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country 9.4.1 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2016-2021) 9.4.2 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size (2016-2027) 10.2 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type 10.2.1 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2027) 10.3 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Age 10.3.1 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2021) 10.3.2 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Age (2022-2027) 10.3.3 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2027) 10.4 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country 10.4.1 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis International (Switzerland) 11.1.1 Novartis International (Switzerland) Company Details 11.1.2 Novartis International (Switzerland) Business Overview 11.1.3 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Introduction 11.1.4 Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.1.5 Novartis International (Switzerland) Recent Development 11.2 Bayer (Germany) 11.2.1 Bayer (Germany) Company Details 11.2.2 Bayer (Germany) Business Overview 11.2.3 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Introduction 11.2.4 Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.2.5 Bayer (Germany) Recent Development 11.3 Acucela (US) 11.3.1 Acucela (US) Company Details 11.3.2 Acucela (US) Business Overview 11.3.3 Acucela (US) Wet Age Related Macular Degeneration (AMD) Introduction 11.3.4 Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.3.5 Acucela (US) Recent Development 11.4 Neurotech Pharmaceuticals (US) 11.4.1 Neurotech Pharmaceuticals (US) Company Details 11.4.2 Neurotech Pharmaceuticals (US) Business Overview 11.4.3 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Introduction 11.4.4 Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.4.5 Neurotech Pharmaceuticals (US) Recent Development 11.5 Ophthotech (US) 11.5.1 Ophthotech (US) Company Details 11.5.2 Ophthotech (US) Business Overview 11.5.3 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Introduction 11.5.4 Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.5.5 Ophthotech (US) Recent Development 11.6 GlaxoSmithKline (US) 11.6.1 GlaxoSmithKline (US) Company Details 11.6.2 GlaxoSmithKline (US) Business Overview 11.6.3 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Introduction 11.6.4 GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.6.5 GlaxoSmithKline (US) Recent Development 11.7 Alimera Sciences (US) 11.7.1 Alimera Sciences (US) Company Details 11.7.2 Alimera Sciences (US) Business Overview 11.7.3 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Introduction 11.7.4 Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.7.5 Alimera Sciences (US) Recent Development 11.8 StemCell (Canada) 11.8.1 StemCell (Canada) Company Details 11.8.2 StemCell (Canada) Business Overview 11.8.3 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Introduction 11.8.4 StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.8.5 StemCell (Canada) Recent Development 11.9 F. Hoffmann-La Roche (Switzerland) 11.9.1 F. Hoffmann-La Roche (Switzerland) Company Details 11.9.2 F. Hoffmann-La Roche (Switzerland) Business Overview 11.9.3 F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Introduction 11.9.4 F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.9.5 F. Hoffmann-La Roche (Switzerland) Recent Development 11.10 Regeneron Pharmaceutical (US) 11.10.1 Regeneron Pharmaceutical (US) Company Details 11.10.2 Regeneron Pharmaceutical (US) Business Overview 11.10.3 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Introduction 11.10.4 Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.10.5 Regeneron Pharmaceutical (US) Recent Development 11.11 Allergan (Ireland) 11.11.1 Allergan (Ireland) Company Details 11.11.2 Allergan (Ireland) Business Overview 11.11.3 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Introduction 11.11.4 Allergan (Ireland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.11.5 Allergan (Ireland) Recent Development 11.12 Adverum Biotechnologies (US) 11.12.1 Adverum Biotechnologies (US) Company Details 11.12.2 Adverum Biotechnologies (US) Business Overview 11.12.3 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Introduction 11.12.4 Adverum Biotechnologies (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.12.5 Adverum Biotechnologies (US) Recent Development 11.13 Gilead Sciences (US) 11.13.1 Gilead Sciences (US) Company Details 11.13.2 Gilead Sciences (US) Business Overview 11.13.3 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Introduction 11.13.4 Gilead Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) 11.13.5 Gilead Sciences (US) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Wet Age-Related Macular Degeneration (Wet AMD) Table 3. Key Players of Dry Age-Related Macular Degeneration (Dry AMD) Table 4. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth by Age (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions (2016-2021) Table 8. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions (2022-2027) Table 10. Wet Age Related Macular Degeneration (AMD) Market Trends Table 11. Wet Age Related Macular Degeneration (AMD) Market Drivers Table 12. Wet Age Related Macular Degeneration (AMD) Market Challenges Table 13. Wet Age Related Macular Degeneration (AMD) Market Restraints Table 14. Global Wet Age Related Macular Degeneration (AMD) Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Wet Age Related Macular Degeneration (AMD) Market Share by Players (2016-2021) Table 16. Global Top Wet Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wet Age Related Macular Degeneration (AMD) as of 2020) Table 17. Ranking of Global Top Wet Age Related Macular Degeneration (AMD) Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Wet Age Related Macular Degeneration (AMD) Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Wet Age Related Macular Degeneration (AMD) Product Solution and Service Table 21. Date of Enter into Wet Age Related Macular Degeneration (AMD) Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million) Table 24. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2016-2021) Table 25. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Age (2016-2021) & (US$ Million) Table 28. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Age (2016-2021) Table 29. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Age (2022-2027) (US$ Million) Table 30. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Age (2022-2027) & (US$ Million) Table 31. North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million) Table 32. North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2021) (US$ Million) Table 34. North America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2022-2027) & (US$ Million) Table 35. North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2021) (US$ Million) Table 40. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age (2022-2027) & (US$ Million) Table 41. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2021) (US$ Million) Table 46. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Age (2022-2027) & (US$ Million) Table 47. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2021) (US$ Million) Table 52. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2022-2027) & (US$ Million) Table 53. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Age (2016-2021) (US$ Million) Table 58. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Age (2022-2027) & (US$ Million) Table 59. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2022-2027) & (US$ Million) Table 61. Novartis International (Switzerland) Company Details Table 62. Novartis International (Switzerland) Business Overview Table 63. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Product Table 64. Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 65. Novartis International (Switzerland) Recent Development Table 66. Bayer (Germany) Company Details Table 67. Bayer (Germany) Business Overview Table 68. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Product Table 69. Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 70. Bayer (Germany) Recent Development Table 71. Acucela (US) Company Details Table 72. Acucela (US) Business Overview Table 73. Acucela (US) Wet Age Related Macular Degeneration (AMD) Product Table 74. Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 75. Acucela (US) Recent Development Table 76. Neurotech Pharmaceuticals (US) Company Details Table 77. Neurotech Pharmaceuticals (US) Business Overview Table 78. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Product Table 79. Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 80. Neurotech Pharmaceuticals (US) Recent Development Table 81. Ophthotech (US) Company Details Table 82. Ophthotech (US) Business Overview Table 83. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Product Table 84. Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 85. Ophthotech (US) Recent Development Table 86. GlaxoSmithKline (US) Company Details Table 87. GlaxoSmithKline (US) Business Overview Table 88. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Product Table 89. GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 90. GlaxoSmithKline (US) Recent Development Table 91. Alimera Sciences (US) Company Details Table 92. Alimera Sciences (US) Business Overview Table 93. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Product Table 94. Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 95. Alimera Sciences (US) Recent Development Table 96. StemCell (Canada) Company Details Table 97. StemCell (Canada) Business Overview Table 98. StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 99. StemCell (Canada) Recent Development Table 100. F. Hoffmann-La Roche (Switzerland) Company Details Table 101. F. Hoffmann-La Roche (Switzerland) Business Overview Table 102. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Product Table 103. F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 104. F. Hoffmann-La Roche (Switzerland) Recent Development Table 105. Regeneron Pharmaceutical (US) Company Details Table 106. Regeneron Pharmaceutical (US) Business Overview Table 107. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Product Table 108. Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 109. Regeneron Pharmaceutical (US) Recent Development Table 110. Allergan (Ireland) Company Details Table 111. Allergan (Ireland) Business Overview Table 112. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Product Table 113. Allergan (Ireland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 114. Allergan (Ireland) Recent Development Table 115. Adverum Biotechnologies (US) Company Details Table 116. Adverum Biotechnologies (US) Business Overview Table 117. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Product Table 118. Adverum Biotechnologies (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 119. Adverum Biotechnologies (US) Recent Development Table 120. Gilead Sciences (US) Company Details Table 121. Gilead Sciences (US) Business Overview Table 122. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Product Table 123. Gilead Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) & (US$ Million) Table 124. Gilead Sciences (US) Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Wet Age Related Macular Degeneration (AMD) Market Share by Type: 2020 VS 2027 Figure 2. Wet Age-Related Macular Degeneration (Wet AMD) Features Figure 3. Dry Age-Related Macular Degeneration (Dry AMD) Features Figure 4. Global Wet Age Related Macular Degeneration (AMD) Market Share by Age: 2020 VS 2027 Figure 5. Above 75 Years Case Studies Figure 6. Above 60 Years Case Studies Figure 7. Above 40 Years Case Studies Figure 8. Wet Age Related Macular Degeneration (AMD) Report Years Considered Figure 9. Global Wet Age Related Macular Degeneration (AMD) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Wet Age Related Macular Degeneration (AMD) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions: 2020 VS 2027 Figure 12. Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions (2022-2027) Figure 13. Global Wet Age Related Macular Degeneration (AMD) Market Share by Players in 2020 Figure 14. Global Top Wet Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wet Age Related Macular Degeneration (AMD) as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Wet Age Related Macular Degeneration (AMD) Revenue in 2020 Figure 16. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2016-2021) Figure 17. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2022-2027) Figure 18. North America Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2027) Figure 20. North America Wet Age Related Macular Degeneration (AMD) Market Share by Age (2016-2027) Figure 21. North America Wet Age Related Macular Degeneration (AMD) Market Share by Country (2016-2027) Figure 22. United States Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2027) Figure 26. Europe Wet Age Related Macular Degeneration (AMD) Market Share by Age (2016-2027) Figure 27. Europe Wet Age Related Macular Degeneration (AMD) Market Share by Country (2016-2027) Figure 28. Germany Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2027) Figure 36. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Share by Age (2016-2027) Figure 37. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Share by Region (2016-2027) Figure 38. China Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2027) Figure 46. Latin America Wet Age Related Macular Degeneration (AMD) Market Share by Age (2016-2027) Figure 47. Latin America Wet Age Related Macular Degeneration (AMD) Market Share by Country (2016-2027) Figure 48. Mexico Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2027) Figure 52. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Share by Age (2016-2027) Figure 53. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Share by Country (2016-2027) Figure 54. Turkey Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Novartis International (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 58. Bayer (Germany) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 59. Acucela (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 60. Neurotech Pharmaceuticals (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 61. Ophthotech (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 62. GlaxoSmithKline (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 63. Alimera Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 64. StemCell (Canada) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 65. F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 66. Regeneron Pharmaceutical (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 67. Allergan (Ireland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 68. Adverum Biotechnologies (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 69. Gilead Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Novartis International (Switzerland) Bayer (Germany) Acucela (US) Neurotech Pharmaceuticals (US) Ophthotech (US) GlaxoSmithKline (US) Alimera Sciences (US) StemCell (Canada) F. Hoffmann-La Roche (Switzerland) Regeneron Pharmaceutical (US) Allergan (Ireland) Adverum Biotechnologies (US) Gilead Sciences (US)